Patents by Inventor Marjo Kestila

Marjo Kestila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nephrin gene and protein
    Patent number: 7799529
    Abstract: The present invention provides for compositions and methods for detecting susceptibility for basement membrane disease, in particular congenital nephrotic syndromes of the Finnish type. The present invention provides for nucleic acids and protein for use in methods and compositions for the diagnosis of disease and identification of small molecule therapeutics for treatment of such disease, in particular of proteinuria associated with kidney disease.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: September 21, 2010
    Assignee: Athena Diagnostics, Inc.
    Inventors: Karl Tryggvason, Marjo Kestila, Ulla Lenkkeri, Minna Mannikko
  • Nephrin gene and protein
    Publication number: 20070009952
    Abstract: The present invention provides for compositions and methods for detecting susceptibility for basement membrane disease, in particular congenital nephrotic syndromes of the Finnish type. The present invention provides for nucleic acids and protein for use in methods and compositions for the diagnosis of disease and identification of small molecule therapeutics for treatment of such disease, in particular of proteinuria associated with kidney disease.
    Type: Application
    Filed: September 12, 2006
    Publication date: January 11, 2007
    Inventors: Karl Tryggvason, Marjo Kestila, Ulla Lenkkeri, Minna Mannikko
  • Nephrin gene and protein
    Patent number: 7105291
    Abstract: The present invention provides for compositions and methods for detecting susceptibility for basement membrane disease, in particular Congenital nephrotic syndromes of the Finnish type. The present invention provides for nucleic acids and protein for use in methods and compositions for the diagnosis of disease and identification of small molecule therapeutics for treatment of such disease, in particular of proteinuria associated with kidney disease.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: September 12, 2006
    Assignee: Biostratum, Inc.
    Inventors: Karl Tryggvason, Marjo Kestila, Ulla Lenkkeri, Minna Mannikko
  • Nephrin gene and protein
    Publication number: 20020004589
    Abstract: The present invention provides for compositions and methods for detecting susceptibility for basement membrane disease, in particular Congenital nephrotic syndromes of the Finnish type. The present invention provides for nucleic acids and protein for use in methods and compositions for the diagnosis of disease and identification of small molecule therapeutics for treatment of such disease, in particular of proteinuria associated with kidney disease.
    Type: Application
    Filed: January 12, 2001
    Publication date: January 10, 2002
    Applicant: Biostratum AB
    Inventors: Karl Tryggvason, Marjo Kestila, Ulla Lenkkeri, Minna Mannikko
  • Nephrin gene and protein
    Patent number: 6207811
    Abstract: The present invention provides for compositions and methods for detecting susceptibility for basement membrane disease, in particular Congenital nephrotic syndromes of the Finnish type. The present invention provides for nucleic acids and protein for use in methods and compositions for the diagnosis of disease and identification of small molecule therapeutics for treatment of such disease, in particular of proteinuria associated with kidney disease.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: March 27, 2001
    Inventors: Karl Tryggvason, Marjo Kestila, Ulla Lenkkeri, Minna Mannikko